Results 111 to 120 of about 23,148 (170)

The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations. [PDF]

Inflammopharmacology
Mohr ETB, Lubschinski TL, Moro PAM, Benvenutti L, Costa NTC, de Sousa PLPB, Sá MM, Hernandes MZ, Milton FA, Santin JR, Dalmarco EM.   +10 more
europepmc   +1 more source

Drug-drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors. [PDF]

Cancer Chemother Pharmacol
Katsuya Y, Takenaka S, Takahashi S, Yamamoto N.   +3 more
europepmc   +1 more source

Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial. [PDF]

Diabetol Metab Syndr
Singh AK, Seshadri KG, Unnikrishnan AG, Kesavadev J, Kalra S, Joshi SR, Pandit K, Sahay RK, Panikar VK, Mithal A, Gadia S, Anthuvan T.   +11 more
europepmc   +1 more source

Clinical and Dermoscopic Evaluation of the Effectiveness of Metformin versus Pioglitazone in Acanthosis Nigricans: A Randomised Controlled Trial. [PDF]

Indian Dermatol Online J
Jain J, Doshi B, Shete AP, Ankad B.
europepmc   +1 more source

Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid. [PDF]

Int J Mol Sci
Harrer DC, Lüke F, Pukrop T, Reichle A, Heudobler D.   +4 more
europepmc   +1 more source

Integrative Machine Learning and Network Analysis of Skeletal Muscle Transcriptomes Identifies Candidate Pioglitazone-Responsive Biomarkers in Polycystic Ovary Syndrome. [PDF]

Genes (Basel)
Al Athamneh A, Farfoura ME, Khaleel A, Connie T.   +3 more
europepmc   +1 more source

Pioglitazone plus (-)-epigallocatechin gallate: a novel approach to enhance osteogenic performance in aged bone marrow mesenchymal stem cells. [PDF]

FEBS Open Bio
Chen CY, Jhang JC, Peng CY, Nguyễn QC, Lin FH, Wu HM, Lin S.   +6 more
europepmc   +1 more source

Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study. [PDF]

Sci Rep
Kim K, Ko SH, Yun JS, Lee KW, Kim ES, Jeong IK, Kim JH, Kim SY, Won KC, Kim M, Cha BS, Kim S, Choi SH, Rhee EJ, Kim SG, Kim BH, Park KS, Ju YC, Heo TW, Ahn YB.   +19 more
europepmc   +1 more source

A Comparative Evaluation of the Effects of Saroglitazar and Pioglitazone on Hepatic and Metabolic Parameters in Type 2 Diabetes Mellitus With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). [PDF]

Cureus
Meher D, Das S, Choudhury A, Sahoo D, Sahu SK, Agarwal V, Prusty B, Ketan Das B, Chappalagavi AS, Gupta S, Sreekumar V.   +10 more
europepmc   +1 more source